Meta Biomed Co., Ltd. (KOSDAQ: 059210)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,975.00
+60.00 (1.53%)
Oct 14, 2024, 3:19 PM KST

Meta Biomed Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
14,80210,0802,6289,522-4,0933,346
Upgrade
Depreciation & Amortization
4,5874,2233,8603,5713,9413,713
Upgrade
Loss (Gain) From Sale of Assets
-1.22-12.62-1,212-1,16095.872.83
Upgrade
Asset Writedown & Restructuring Costs
1,0151,015487.37541.234,661123.63
Upgrade
Loss (Gain) From Sale of Investments
-283.82-90.29-53.65-51.16260.618.79
Upgrade
Loss (Gain) on Equity Investments
-645.06-682.88-373.09-537.62-468.69-392.13
Upgrade
Provision & Write-off of Bad Debts
-133.67-158.44-172.39-1,3768.39178.85
Upgrade
Other Operating Activities
-4,337-2,9262,115-1,63757.12945.21
Upgrade
Change in Accounts Receivable
2,837186.61-1,024-171.242,190-2,183
Upgrade
Change in Inventory
1,711-470.44926.992,038-1,989-2,204
Upgrade
Change in Accounts Payable
-2,366304.0593.14-1,503-513.0593.06
Upgrade
Change in Other Net Operating Assets
1,768-1,2511,8841,900712-778.86
Upgrade
Operating Cash Flow
18,95210,2179,15911,1364,8622,865
Upgrade
Operating Cash Flow Growth
160.86%11.55%-17.75%129.05%69.70%-
Upgrade
Capital Expenditures
-12,977-11,489-15,395-2,067-2,227-7,561
Upgrade
Sale of Property, Plant & Equipment
3.38128.067.451,4136.530.54
Upgrade
Cash Acquisitions
---2,295-2.45--
Upgrade
Divestitures
---535.01--
Upgrade
Sale (Purchase) of Intangibles
-37.95-5.4385.95-33.29-824.5-508.03
Upgrade
Investment in Securities
-21,8521,116-167.96,349-7,464223.18
Upgrade
Other Investing Activities
-1,402-1,4513,186130593.941,118
Upgrade
Investing Cash Flow
-36,265-11,701-14,5786,324-9,915-6,727
Upgrade
Long-Term Debt Issued
-11,37537,0831,94916,7597,357
Upgrade
Long-Term Debt Repaid
--11,940-27,828-17,827-5,123-6,318
Upgrade
Net Debt Issued (Repaid)
23,743-565.379,255-15,87811,6351,040
Upgrade
Repurchase of Common Stock
---63.26---132.12
Upgrade
Dividends Paid
-457.42-457.42-458.02-229.01-232.67-233.28
Upgrade
Other Financing Activities
-168-0-00-
Upgrade
Financing Cash Flow
23,117-1,0238,734-16,10711,403674.26
Upgrade
Foreign Exchange Rate Adjustments
337.7777.02-201.36121.38-60.4850.35
Upgrade
Miscellaneous Cash Flow Adjustments
-0--00--
Upgrade
Net Cash Flow
6,142-2,4303,1131,4746,288-3,138
Upgrade
Free Cash Flow
5,975-1,271-6,2369,0692,634-4,696
Upgrade
Free Cash Flow Growth
---244.28%--
Upgrade
Free Cash Flow Margin
6.63%-1.53%-9.04%15.43%5.85%-7.91%
Upgrade
Free Cash Flow Per Share
244.78-55.59-272.48396.00114.32-201.62
Upgrade
Cash Interest Paid
2,3072,1761,259733.311,2781,017
Upgrade
Cash Income Tax Paid
92.0680379.03357.43293.62-42.04
Upgrade
Levered Free Cash Flow
12,379-3,338-6,1755,6501,895-4,182
Upgrade
Unlevered Free Cash Flow
14,192-1,891-5,3066,3662,527-3,438
Upgrade
Change in Net Working Capital
-14,9011,246-2,790-1,607-66.212,678
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.